Analysis of response pattern for patients with recurrent or metastatic colorectal cancer treated with Irinotecan, 5-FU, and low dose leucovorin (modified FOLFIRI) as 1st line chemotherapy

Myung Ah Lee,Jin-Hyoung Kang,Yeong Seon Hong,Kyung Shik Lee,S. M. Park,W.K. Kang

Analysis of response pattern for patients with recurrent or metastatic colorectal cancer treated with Irinotecan, 5-FU, and low dose leucovorin (modified FOLFIRI) as 1st line chemotherapy

2016

Myung Ah Lee
Jin-Hyoung Kang
Yeong Seon Hong
Kyung Shik Lee
S. M. Park
W.K. Kang

13546 Background: Irinotecan in combination with 5-fluorouracil (5-FU) and high dose leucovorin (LV), known as FOLFIRI regimen, has shown activity in recurrent or metastatic colorectal cancer. We a...

Keywords:

Irinotecan
Oncology
Colorectal cancer
Pathology
FOLFIRI Regimen
FOLFIRI
Medicine
Chemotherapy
Internal medicine
low dose

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations